InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.17
(
0.00%
)
US TECH 100
19,217.20
(
-0.22%
)
Dow Jones
39,134.76
(
0.00%
)
Brent Oil
85.05
(
0.05%
)
Bitcoin
63,628.51
(
-1.84%
)
Post# of 647762
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Covid19freak

Send PM Follow Ignore
Followers 10
Posts 1251
Boards Moderated 0
Alias Born 07/20/2020

Covid19freak

Re: None

Tuesday, 08/23/2022 1:55:23 PM

Tuesday, August 23, 2022 1:55:23 PM

Post# of 647762
(VAXX) $2.45 --Best Covid Vaccine ? Company about to release Phase 3 results if positive then stock could be a multibagger


"The Phase 3 heterologous boost study evaluating UB-612 against COVID-19 in subjects who have received primary immunization from mRNA, adenovirus vector, or inactivated viral vaccines is ongoing. Vaxxinity expects a topline readout in the second half of 2022, and if successful, these data will support global marketing authorization applications."

Vaxxinity looks to pioneer the next revolution in pharma
https://www.pharmavoice.com/news/vaxxinity-to-pioneer-the-next-revolution/617229/
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up